Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Sci Rep ; 13(1): 22989, 2023 12 27.
Article in English | MEDLINE | ID: mdl-38151496

ABSTRACT

Nonverbal acoustic parameters of the human voice provide cues to a vocaliser's sex, age, and body size that are relevant in human social and sexual communication, and also increasingly so for computer-based voice recognition and synthesis technologies. While studies have shown some capacity in human listeners to gauge these biological traits from unseen speakers, it remains unknown whether speech complexity improves accuracy. Here, in over 200 vocalisers and 1500 listeners of both sexes, we test whether voice-based assessments of sex, age, height and weight vary from isolated vowels and words, to sequences of vowels and words, to full sentences or paragraphs. We show that while listeners judge sex and especially age more accurately as speech complexity increases, accuracy remains high across speech types, even for a single vowel sound. In contrast, the actual heights and weights of vocalisers explain comparatively less variance in listener's assessments of body size, which do not vary systematically by speech type. Our results thus show that while more complex speech can improve listeners' biological assessments, the gain is ecologically small, as listeners already show an impressive capacity to gauge speaker traits from extremely short bouts of standardised speech, likely owing to within-speaker stability in underlying nonverbal vocal parameters such as voice pitch. We discuss the methodological, technological, and social implications of these results.


Subject(s)
Speech Perception , Voice , Male , Female , Humans , Speech , Body Size , Communication , Speech Acoustics
2.
Front Vet Sci ; 10: 1227683, 2023.
Article in English | MEDLINE | ID: mdl-37655260

ABSTRACT

Background: Dogs present a significant opportunity for studies in comparative oncology. However, the study of cancer biology phenomena in canine cells is currently limited by restricted availability of validated antibody reagents and techniques. Here, we provide an initial characterization of the expression and activity of key components of the DNA Damage Response (DDR) in a panel of hematopoietic canine cancer cell lines, with the use of commercially available antibody reagents. Materials and methods: The techniques used for this validation analysis were western blot, qPCR, and DNA combing assay. Results: Substantial variations in both the basal expression (ATR, Claspin, Chk1, and Rad51) and agonist-induced activation (p-Chk1) of DDR components were observed in canine cancer cell lines. The expression was stronger in the CLBL-1 (B-cell lymphoma) and CLB70 (B-cell chronic lymphocytic leukemia) cell lines than in the GL-1 (B-cell leukemia) cell line, but the biological significance of these differences requires further investigation. We also validated methodologies for quantifying DNA replication dynamics in hematopoietic canine cancer cell lines, and found that the GL-1 cell line presented a higher replication fork speed than the CLBL-1 cell line, but that both showed a tendency to replication fork asymmetry. Conclusion: These findings will inform future studies on cancer biology, which will facilitate progress in developing novel anticancer therapies for canine patients. They can also provide new knowledge in human oncology.

3.
Cell Physiol Biochem ; 57(2): 54-62, 2023 Mar 22.
Article in English | MEDLINE | ID: mdl-36945896

ABSTRACT

BACKGROUND/AIMS: Glucose metabolism has been proven as an essential process for proliferating keratinocytes, which highlights the importance of glucose transporter-1 (GLUT1) not only in the onset of psoriasis but also in the progression and severity of this inflammation-driven disease. In this study, we attempted to find a connection between proinflammatory cytokines (IL-6, IL-17, IL-23, IL-36, TNF-α), a skin inflammation inducing agent - imiquimod (IMQ) and GLUT1 expression. METHODS: Human keratinocyte HaCaT cell line was incubated with exogenous cytokines: IL-6, IL-17A, IL-23, IL-36, TNF-α at a final concentration of 100 ng/ml, or with 1 µM of IMQ, for 48 h. Following the stimulation, glucose uptake and GLUT1 expression were evaluated. The activity of GLUT1 was measured in the presence of a selective GLUT1 inhibitor, BAY-876. The expression of GLUT1 was examined by immunofluorescence and quantified by qPCR, Western blotting and densitometry. RESULTS: The results from qPCR analysis showed that the administration of exogenous IL-6, IL-17, IL-23 and IL-36 to HaCaT cells resulted in upregulation of GLUT1-encoding SLC2A1 gene, while TNF-α had no significant effect. The same results were confirmed by immunofluorescence analysis, as the fluorescent intensity of GLUT1 was elevated following cytokine and IMQ stimulation. Western blot and densitometry showed that all examined cytokines, as well as IMQ, increased GLUT1 expression. HaCaT cells displayed an improved intracellular 2-deoxy-D-glucose (2-DG) uptake and GLUT1 activity after stimulation by exogenous cytokines and IMQ. The highest uptake of 2-DG was observed after IL-23 stimulation (1.93x) and the lowest after TNF-α stimulation (1.07x). BAY-876 inhibited the 2-DG uptake compared to control. CONCLUSION: Our findings suggest that cytokines and IMQ may play a key role in regulating GLUT1 expression in HaCaT cells. We believe that GLUT1 overexpression could potentially be utilized in the targeted treatment of psoriasis.


Subject(s)
Cytokines , Psoriasis , Humans , Animals , Mice , Imiquimod/pharmacology , Imiquimod/metabolism , Imiquimod/therapeutic use , Cytokines/metabolism , Interleukin-17/metabolism , Glucose Transporter Type 1/genetics , Glucose Transporter Type 1/metabolism , Tumor Necrosis Factor-alpha/pharmacology , Tumor Necrosis Factor-alpha/metabolism , Interleukin-6/metabolism , Keratinocytes/metabolism , Psoriasis/drug therapy , Inflammation/metabolism , Interleukin-23/metabolism , Interleukin-23/pharmacology , Interleukin-23/therapeutic use , Disease Models, Animal , Skin/metabolism , Mice, Inbred BALB C
4.
J Speech Lang Hear Res ; 65(10): 3674-3694, 2022 10 17.
Article in English | MEDLINE | ID: mdl-36167068

ABSTRACT

PURPOSE: The human voice is a powerful and evolved social tool, with hundreds of studies showing that nonverbal vocal parameters robustly influence listeners' perceptions of socially meaningful speaker traits, ranging from perceived gender and age to attractiveness and trustworthiness. However, these studies have utilized a wide variety of voice stimuli to measure listeners' voice-based judgments of these traits. Here, in the largest scale study known to date, we test whether listeners judge the same unseen speakers differently depending on the complexity of the neutral speech stimulus, from single vowel sounds to a full paragraph. METHOD: In a playback experiment testing 2,618 listeners, we examine whether commonly studied voice-based judgments of attractiveness, trustworthiness, dominance, likability, femininity/masculinity, and health differ if listeners hear isolated vowels, a series of vowels, single words, single sentences (greeting), counting from 1 to 10, or a full paragraph recited aloud (Rainbow Passage), recorded from the same 208 men and women. Data were collected using a custom-designed interface in which vocalizers and traits were randomly assigned to raters. RESULTS: Linear-mixed models show that the type of voice stimulus does indeed consistently affect listeners' judgments. Overall, ratings of attractiveness, trustworthiness, dominance, likability, health, masculinity among men, and femininity among women increase as speech duration increases. At the same time, speaker-level regression analyses show that interindividual differences in perceived speaker traits are largely preserved across voice stimuli, especially among those of a similar duration. CONCLUSIONS: Socially relevant perceptions of speakers are not wholly changed but rather moderated by the length of their speech. Indeed, the same vocalizer is perceived in a similar way regardless of which neutral statements they speak, with the caveat that longer utterances explain the most shared variance in listeners' judgments and elicit the highest ratings on all traits, possibly by providing additional nonverbal information to listeners. SUPPLEMENTAL MATERIAL: https://doi.org/10.23641/asha.21158890.


Subject(s)
Speech Perception , Voice , Female , Humans , Judgment , Male , Masculinity , Speech , Speech Acoustics
5.
J Vet Intern Med ; 36(4): 1508-1524, 2022 Jul.
Article in English | MEDLINE | ID: mdl-35801813

ABSTRACT

BACKGROUND: The endocannabinoid system (ECS) is composed of cannabinoid receptors type 1 (CBR1) and type 2 (CBR2), cannabinoid-based ligands (endogenous chemically synthesized phytocannabinoids), and endogenous enzymes controlling their concentrations. Cannabinoid receptors (CBRs) have been identified in invertebrates and in almost all vertebrate species in the central and peripheral nervous system as well as in immune cells, where they control neuroimmune homeostasis. In humans, rodents, dogs, and cats, CBRs expression has been confirmed in the skin, and their expression and tissue distribution become disordered in pathological conditions. Cannabinoid receptors may be a possible therapeutic target in skin diseases. OBJECTIVES: To characterize the distribution and cellular expression of CBRs in the skin of horses under normal conditions. ANIMALS: Fifteen healthy horses. METHODS: Using full-thickness skin punch biopsy samples, skin-derived primary epidermal keratinocytes and dermal-derived cells, we performed analysis of Cnr1 and Cnr2 genes using real-time PCR and CBR1 and CBR2 protein expression by confocal microscopy and Western blotting. RESULTS: Normal equine skin, including equine epidermal keratinocytes and dermal fibroblast-like cells, all exhibited constant gene and protein expression of CBRs. CONCLUSIONS AND CLINICAL IMPORTANCE: Our results represent a starting point for developing and translating new veterinary medicine-based pharmacotherapies using ECS as a possible target.


Subject(s)
Cannabinoids , Skin , Animals , Horses , Receptors, Cannabinoid/genetics , Tissue Distribution
6.
J Immunol Res ; 2022: 1208970, 2022.
Article in English | MEDLINE | ID: mdl-35450396

ABSTRACT

Rheumatoid arthritis (RA) is one of the most prevalent autoimmune diseases, affecting approximately 1% of the total global population. Curcumin, a natural polyphenol is a substance that could potentially mitigate the course of this disease. To evaluate curcumin's anti-inflammatory impact on synoviocytes in the RA model, a set of experiments was conducted on SW982 cells, stimulated by IL-1ß, IL-6, or TNF-α to emulate inflammation. During the research, the curcumin effect was evaluated by measuring cell survivability, expression of MMP1 gene, subcellular localization of P70S6K1 protein, and its phosphorylated form and amount of produced IL-6 and TNF-α. Results of conducted experiments presented a positive impact of curcumin on synoviocytes in the RA model, by reducing SW982 cells' survivability, decreasing levels of MMP1 gene expression and TNF-α protein production, which altogether confirm beneficial effects of the curcumin therapy in a RA in vitro model.


Subject(s)
Arthritis, Rheumatoid , Curcumin , Synoviocytes , Cells, Cultured , Curcumin/pharmacology , Curcumin/therapeutic use , Fibroblasts , Humans , Interleukin-6/genetics , Matrix Metalloproteinase 1/genetics , Tumor Necrosis Factor-alpha/metabolism
7.
Cells ; 10(2)2021 01 31.
Article in English | MEDLINE | ID: mdl-33572647

ABSTRACT

(1) Background: Poly(ADP-ribose) polymerase 1) (PARP1) is a pleiotropic enzyme involved in several cellular processes, e.g., DNA damage repair, regulation of mitosis, and immune response. Little is known about the role of PARP1 in melanoma development and progression. We aimed to investigate the prognostic significance of PARP1 expression in cutaneous melanoma through evaluation of mRNA and protein levels of PARP1 in normal melanocytes and melanoma cell lines, as well as in patients' tissue material from surgical resections. (2) Methods: An in vitro model was based on two types of normal human melanocytes (HEMn-DP and HEMn-LP) and four melanoma cell lines (A375, WM1341D, Hs294T, and WM9). PARP1 mRNA gene expression was estimated using real-time polymerase chain reaction (RT-PCR), whereas the protein level of PARP1 was evaluated by fluorescence confocal microscopy and then confirmed by Western Blotting analysis. The expression of PARP1 was also assessed by immunohistochemistry in formalin-fixed paraffin-embedded tissues of 128 primary cutaneous melanoma patients and correlated with follow-up and clinicopathologic features. (3) Results: The in vitro study showed that melanoma cells exhibited significantly higher PARP1 expression at mRNA and protein levels than normal melanocytes. High PARP1 expression was also associated with the invasiveness of tumor cells. Elevated nuclear PARP1 expression in patients without nodal metastases strongly correlated with significantly shorter disease-free survival (p = 0.0015) and revealed a trend with shorter cancer-specific overall survival (p = 0.05). High PARP1 immunoreactivity in the lymph node-negative group of patients was significantly associated with higher Breslow tumor thickness, presence of ulceration, and a higher mitotic index (p = 0.0016, p = 0.023, and p < 0.001, respectively). In patients with nodal metastases, high PARP1 expression significantly correlated with the presence of microsatellitosis (p = 0.034), but we did not confirm the prognostic significance of PARP1 expression in these patients. In the entire analyzed group of patients (with and without nodal metastases at the time of diagnosis), PARP1 expression was associated with a high mitotic index (p = 0.001) and the presence of ulceration (p = 0.036). Moreover, in patients with elevated PARP1 expression, melanoma was more frequently located in the skin of the head and neck region (p = 0.015). In multivariate analysis, high PARP1 expression was an independent unfavorable prognosticator in lymph node-negative cutaneous melanoma patients. (4) Conclusions: In vitro molecular biology approaches demonstrated enhanced PARP1 expression in cutaneous melanoma. These results were confirmed by the immunohistochemical study with clinical parameter analysis, which showed that a high level of PARP1 correlated with unfavorable clinical outcome. These observations raise the potential role of PARP1 inhibitor-based therapy in cutaneous melanoma.


Subject(s)
Melanoma/genetics , Poly (ADP-Ribose) Polymerase-1/therapeutic use , Skin Neoplasms/genetics , Adolescent , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Melanoma/pathology , Middle Aged , Phenotype , Poly (ADP-Ribose) Polymerase-1/pharmacology , Prognosis , Skin Neoplasms/pathology , Young Adult , Melanoma, Cutaneous Malignant
8.
Biomed Res Int ; 2018: 7489316, 2018.
Article in English | MEDLINE | ID: mdl-30148172

ABSTRACT

Psoriasis is an immunogenetic skin disease manifesting as plaque lesions on the skin. Patients with psoriasis frequently suffer from itch, an unpleasant sensation causing a desire to scratch. Psoriatic itch is mainly transmitted by unmyelinated C-fibers; however, the exact molecular mechanism of psoriatic itch is still unexplained. Protein gene product 9.5 (PGP 9.5) is a panneurological marker commonly used for analysis of peripheral peptidergic and nonpeptidergic nerves and identification of cutaneous neuro-immune-endocrine cells. However, some studies suggested that nonneuronal cells, like keratinocytes, may also express PGP 9.5. This phenomenon might be linked with impaired axonal transport, keratinocyte injury, or dysfunctions of neuro-immune-cutaneous connections. The aim of this study was to analyze the expression of PGP 9.5 in psoriatic skin. We observed significantly altered density of PGP 9.5-positive axonal nerve terminals in pruritic lesional (p=0.04) and nonlesional psoriatic skin (p>0.001) compared with controls. In contrast, no significant differences were observed between psoriatic skin without itch and controls. Furthermore, PGP 9.5 expression by suprabasal keratinocytes (SBKs) was significantly increased in itchy skin lesions (p=0.007) compared to skin without itch, and a positive correlation was observed between PGP 9.5 expression and itch intensity (r=0.64; p=0.02). Our findings indicate changes in peripheral innervations and psoriatic keratinocytes, which may influence neuro-immune-cutaneous homeostasis and modulate itch transmission.


Subject(s)
Keratinocytes/metabolism , Psoriasis/metabolism , Ubiquitin Thiolesterase/metabolism , Adult , Aged , Epidermis , Female , Humans , Male , Middle Aged , Pruritus/metabolism , Skin/innervation , Young Adult
9.
Int J Mol Sci ; 19(7)2018 06 26.
Article in English | MEDLINE | ID: mdl-29949925

ABSTRACT

Adhesion is critical for the maintenance of cellular structures as well as intercellular communication, and its dysfunction occurs prevalently during cancer progression. Recently, a growing number of studies indicated the ability of oxygen to regulate adhesion molecules expression, however, the influence of physiological hypoxia (physioxia) on cell adhesion remains elusive. Thus, here we aimed: (i) to develop an optical tweezers based assay to precisely evaluate single diffuse large B-cell lymphoma (DLBCL) cell adhesion to neighbor cells (mesenchymal stromal cells) and extracellular matrix (Matrigel) under normoxia and physioxia; and, (ii) to explore the role of integrins in adhesion of single lymphoma cell. We identified the pronouncedly reduced adhesive properties of lymphoma cell lines and primary lymphocytes B under physioxia to both stromal cells and Matrigel. Corresponding effects were shown in bulk adhesion assays. Then we emphasized that impaired ß1, ß2 integrins, and cadherin-2 expression, studied by confocal microscopy, account for reduction in lymphocyte adhesion in physioxia. Additionally, the blockade studies conducted with anti-integrin antibodies have revealed the critical role of integrins in lymphoma adhesion. To summarize, the presented approach allows for precise confirmation of the changes in single cell adhesion properties provoked by physiological hypoxia. Thus, our findings reveal an unprecedented role of using physiologically relevant oxygen conditioning and single cell adhesion approaches when investigating tumor adhesion in vitro.


Subject(s)
Bone Marrow/pathology , Extracellular Matrix/metabolism , Hypoxia/pathology , Lymphoma, Large B-Cell, Diffuse/pathology , Optical Tweezers , Antigens, CD/metabolism , Cadherins/metabolism , Cell Adhesion , Cell Adhesion Molecules/metabolism , Cell Line, Tumor , Cell Proliferation , Cell Survival , Collagen/metabolism , Drug Combinations , Humans , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Integrin beta1/metabolism , Laminin/metabolism , Lasers , Lymphoma, Large B-Cell, Diffuse/metabolism , Mesenchymal Stem Cells/metabolism , Proteoglycans/metabolism , Single-Cell Analysis , Stromal Cells/pathology , Time Factors
10.
Acta Derm Venereol ; 97(5): 564-570, 2017 May 08.
Article in English | MEDLINE | ID: mdl-27958613

ABSTRACT

Psoriasis is an inflammatory immunogenetic skin disease, often accompanied by itch. Opioid receptors are known regulators of itch sensation in the central nervous system. In the brain, µ-opioid receptors may potentiate itch, while activation of κ-opioid receptors may reduce or even alleviate itch; however, the role of opioid receptors in itch perception in the skin is poorly understood. To further elucidate the role of opioid receptors in the neurobiology of psoriatic itch, punch biopsies of non-lesional and lesional skin of patients with psoriasis and healthy controls were studied. Real-time polymerase chain reaction and immunofluorescence microscopy were used to detect opioid receptor genes and protein expression, respectively. The OPRK1/κ-opioid receptor pathway was found to be downregulated in lesional skin of psoriasis, correlating positively with itch sensation. In contrast, the OPRM1/µ-opioid receptor system was uniformly expressed by epidermal keratinocytes in all analysed groups. These findings suggest that imbalance of epidermal opioid receptors may result in disordered neuroepidermal homeostasis in psoriasis, which could potentiate transmission of itch.


Subject(s)
Epidermis/chemistry , Pruritus/metabolism , Psoriasis/metabolism , Receptors, Opioid, kappa/analysis , Receptors, Opioid, mu/analysis , Adult , Aged , Biopsy , Case-Control Studies , Epidermis/pathology , Female , Fluorescent Antibody Technique , Humans , Keratinocytes/chemistry , Male , Microscopy, Fluorescence , Middle Aged , Pruritus/genetics , Pruritus/pathology , Psoriasis/genetics , Psoriasis/pathology , RNA, Messenger/genetics , Real-Time Polymerase Chain Reaction , Receptors, Opioid, kappa/genetics , Receptors, Opioid, mu/genetics , Sensory Thresholds , Signal Transduction , Young Adult
11.
Postepy Hig Med Dosw (Online) ; 67: 982-95, 2013 Sep 18.
Article in Polish | MEDLINE | ID: mdl-24088542

ABSTRACT

Development of vascular and hematopoietic systems during organogenesis occurs at the same time. During vasculogenesis, a small part of cells does not undergo complete differentiation but stays on this level, "anchored" in tissue structures described as stem cell niches. The presence of blood vessels within tissue stem cell niches is typical and led to identification of niches and ensures that they are functioning. The three-layer biostructure of vessel walls for artery and vein, tunica: intima, media and adventitia, for a long time was defined as a mechanical barrier between vessel light and the local tissue environment. Recent findings from vascular biology studies indicate that vessel walls are dynamic biostructures, which are equipped with stem and progenitor cells, described as vascular wall-resident stem cells/progenitor cells (VW-SC/PC). Distinct zones for vessel wall harbor heterogeneous subpopulations of VW-SC/PC, which are described as "subendothelial or vasculogenic zones". Recent evidence from in vitro and in vivo studies show that prenatal activity of stem and progenitor cells is not only limited to organogenesis but also exists in postnatal life, where it is responsible for vessel wall homeostasis, remodeling and regeneration. It is believed that VW-SC/PC could be engaged in progression of vascular disorders and development of neointima. We would like to summarize current knowledge about mesenchymal and progenitor stem cell phenotype with special attention to distribution and biological properties of VW-SC/PC in biostructures of intima, media and adventitia niches. It is postulated that in the near future, niches for VW-SC/PC could be a good source of stem and progenitor cells, especially in the context of vessel tissue bioengineering as a new alternative to traditional revascularization therapies.


Subject(s)
Endothelium, Vascular/cytology , Stem Cells/cytology , Vascular Diseases/pathology , Arteries/cytology , Arteries/enzymology , Cell Differentiation , Disease Progression , Humans , Neointima/pathology , Organogenesis , Stem Cell Niche , Vascular Diseases/therapy
12.
Exp Dermatol ; 18(8): 669-79, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19664006

ABSTRACT

Cannabinoids and their derivatives are group of more than 60 biologically active chemical agents, which have been used in natural medicine for centuries. The major agent of exogenous cannabinoids is Delta(9)-tetrahydrocannabinol (Delta(9)-THC), natural psychoactive ingredient of marijuana. However, psychoactive properties of these substances limited their use as approved medicines. Recent discoveries of endogenous cannabinoids (e.g. arachidonoylethanolamide, 2-arachidonoylglycerol or palmithyloethanolamide) and their receptors initiated discussion on the role of cannabinoid system in physiological conditions as well as in various diseases. Based on the current knowledge, it could be stated that cannabinoids are important mediators in the skin, however their role have not been well elucidated yet. In our review, we summarized the current knowledge about the significant role of the cannabinoid system in the cutaneous physiology and pathology, pointing out possible future therapeutic targets.


Subject(s)
Cannabinoids/metabolism , Dermatology/methods , Skin Diseases/therapy , Skin/metabolism , Animals , Cannabinoid Receptor Modulators/metabolism , Cannabinoid Receptor Modulators/therapeutic use , Cannabinoids/therapeutic use , Chemistry, Pharmaceutical/methods , Drug Design , Humans , Immune System , Keratinocytes/cytology , Models, Biological , Models, Chemical , Signal Transduction , Skin/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...